Politics
Open Access Policy
Acta Medica provides immediate open access to its content, based on the principle that offering the public free access to research contributes to a greater global exchange of knowledge.
It operates on the basis of the Budapest Open Access Declaration - BOAI 2002. In accordance with this Open Access policy, users are permitted to read, download, copy, distribute, print, search or link to the full texts of articles, or use them for any lawful purpose, without any financial, legal or technical barriers, other than those that are inseparable from access to the Internet itself" (http://www.budapestopenaccessinitiative.org/translations/spanish-translation).
In accordance with this Open Access policy, at no stage of the publication process are there any fees of any kind for subscription, submission, processing, publication or reading of articles in our journal.
Content License
This site is licensed under a Creative Commons Attribution- Noncommercial ( CC BY-NC) license: This license allows sharing (copying and redistributing the material in any medium or format) and adaptation (remix, transform , and build upon the material), under the following conditions: authorship is acknowledged, the materials are not used for commercial purposes, and the new creations are licensed under the same terms.
For more information, please visit: https://creativecommons.org/licenses/by-nc/4.0/deed.es
Digital preservation policies
Acta Medica journal adheres to the computer security and preservation policies established for the Health Network by the National Center for Medical Sciences Information (INFOMED).
Archive Preservation Policy
Journal platform service provider system on the Infomed servers (Cuba's health network). In turn, the Infomed servers have a file preservation mechanism based on their own policies and mechanisms.
This journal uses the LOCKSS system to create a distributed archive among participating libraries, allowing these libraries to create permanent archives of the journal for preservation and restoration purposes.
Application of publication charges
This journal DOES NOT APPLY CHARGES FOR PROCESSING OR PUBLICATION OF ARTICLES
Anti-plagiarism policy
Plagiarism is the copying or misuse of another person's intellectual property. Researchers should not present parts of other people's work or data as their own. Manuscripts will be screened for plagiarism.
This journal uses an electronic match detection system as part of its editorial management to ensure the quality of the publication, which contributes to the prevention of possible plagiarism. Articles with a match level above 50% will be rejected.
All articles received by Acta Medica are verified by the editors before and during the publication process using specific tools such as: StrikePlagiarism, to detect coincidences in the texts.
The Editorial Committee will analyze each particular case in relation to the ethical violation and will take the pertinent measures according to the case. In the event of a complaint or detection of plagiarism, the Editorial Committee will establish a commission of experts to investigate and determine the violation. If proven, a note will be included in the published article and the institution that supports the work, the employer, sponsor, or the competent national body will be notified.
Policy on the sections of the journal
Acta Medica predominantly publishes original research articles. It also considers for publication review articles, case reports, case series, letters to the editor, opinion articles and editorials. It will also publish any other type of article that is decided for communication purposes. Articles that are published due to their importance even if they do not meet the characteristics established in the publication standards will be considered as Special.
Policy on the editorial process
This journal uses an electronic system for editorial management. All processes that include the activity will be carried out through the platform. Submissions or personal communications using other media are not permitted.
About submitted manuscripts
As part of the adoption of the universal principles of Open Science in favor of the credibility and transparency of research results, Acta Medica Journal accepts manuscripts deposited in Preprints servers (see preprint submission policy). It is the duty of the authors to declare the permanence of their manuscripts in these repositories. The submitted manuscripts will be subject to a first evaluation to determine the relevance to the thematic coverage of the journal and compliance with the established regulations. Documents that do not meet these initial requirements will be returned.
Policy on the evaluation of manuscripts
The journal Acta Medica carries out a scientific evaluation of all submitted manuscripts using open and closed (double-blind) methods as needed.
Manuscripts accepted after the first evaluation will be subject to evaluation. If the document is accepted with modifications, the authors will have up to 15 calendar days to return it with the corrections; otherwise, they will have to send it again and the process will begin again. The editorial team undertakes to give a verdict on the evaluation process within a period of no more than 90 days.
Original research articles and systematized bibliographic reviews are prioritized over other documents.
Approved manuscripts will be published within a maximum period of one year from the date of submission.
- About the technical process
The technical process includes the correction, design and layout of the manuscript, at which time the authors will receive the corrected and laid out versions for approval. In order to examine and approve the versions, the authors will notify their approval within a period of no more than 72 hours from the date of submission. After this deadline, the article will remain pending.
Authorship Policy
The journal recognizes the people who sign as authors as long as they meet the universally established criteria for authors of scientific articles. Authors of original articles will regularly be asked to send the authorship declaration signed by each of them and where their role in the research is explained. The editorial committee reserves the right to accept certain authors in relation to the declared role and the scope of the research. For the authorship declaration, the CRediT taxonomy is used (CRediT – Contributor Role Taxonomy).
Copyright Policy
This journal is copyright protected from the moment of submission. However, it cedes part of the copyright by displaying a Creative Commons 4.0 license ( cc-by-nc ), which allows the use of the work to share (copy and redistribute the material in any medium or format) and adapt (remix, transform and build upon the material) as long as the exclusive mention is made of the publication in the journal as the primary source. However, it may not be commercialized with it.
Policy on prior publications and presentations at events
Acta Medica will not consider any original research work or component of a research work that has been published or is under consideration for publication elsewhere. Theses or dissertations are not considered prior publications. Publication of research articles on non-profit preprint servers such as: SciELO Preprints, arXiv.org, bioRxiv.org, ChemRxiv.org, medRxiv.org and similar is acknowledged. Distribution on the Internet in other ways may be considered prior publication and may compromise the originality of the article as a submission to a scientific journal. While manuscripts are under peer review, they should not be published in any instance. If any press coverage is to be conducted in relation to the content of the manuscript, it is recommended to do so after the document has been published.
Preprint Policy
Acta Medica suggests and approves that author of articles publish on Preprints Servers as long as they notify the journal about this publication.
Preprints server for these purposes. https://preprints.scielo.org/index.php/scielo/index
Conflict of Interest Declaration Policy
Authors must declare in their research if there are conflicts of interest in relation to the research results proposed and will be responsible for the information provided. The declaration of conflict of interest is a section within the scientific article.
Policy on ethical violations
This journal adheres to all international best practice initiatives for scientific publication and uses the algorithms of the Committee on Publication Ethics (COPE) to resolve all cases of misconduct in scientific publishing.
Policy on publication frequency
The journal publishes in Continuous Publication mode.
Policy on languages of publication
The journal predominantly publishes articles in Spanish, but encourages publication in English provided the author (s) are native English speakers. English versions of articles in Spanish-by-Spanish speakers must have a professional translation certification.
Policy on the document referencing system
The journal uses the NLM style or Vancouver style for bibliographic referencing of articles.
Privacy Policy
Names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
Policy on errors after publication
Acta Medica requires authors to thoroughly review the final version of the manuscript before publication. Authors assume responsibility for any errors not detected before publication. Errors found after publication will be assessed by the Editorial Committee, which will decide whether to replace the current version or publish an erratum.
Policy on the publication of clinical trials
As indicated by the International Committee of Medical Journal Editors (ICMJE), to which Acta Medica adheres, for the publication of Clinical Trials, prior registration in any of the specialized sites is required. The list issued by the WHO is recommended (https://www.who.int/clinical-trials-registry-platform/network/primary-registries).
Documents must bear the Clinical Trial registration number.
Policy on the publication of special issues or supplements
Special issues or supplements respond to a need to communicate specifically about a topic or event, although the so-called proceeding issues already exist for the latter .
The publication of a special issue of the journal Acta Medica is subject to the situations described above. Its structure and length will be determined by the Editorial Committee, in conjunction with the editorial processing unit or Publisher (Editorial Ciencias Médicas). An ad hoc team may be selected to carry out the activity.
On the publication of advertisements or commercial promotions
Acta Medica does not promote advertisements for commercial products that function as sponsors. However, in the context of scientific activity, the pages of the journal can be clear vehicles for dissemination. Courses, workshops and events related to the central theme of the publication can have a space in which to be displayed.
Policy on Open Research Data
The Acta Medica journal promotes the openness of research data, as long as the level of confidentiality allows it. As part of compliance with the principles of Open Science, the author may present his or her research data on any of the servers available internationally for such purposes, which guarantees compliance with the FAIR principles (Findability , Accessibility , Interoperability , and Reusability ).
The following are recommended:
DataCite , The Dataverse Network, Zenod, SciELO Data
Policy on interoperability between information systems
Dublin Core metadata scheme and the OAI-PMH exchange protocol that allows access and transmission of metadata between the data provider and the collectors, allowing retrieval, filtering, reporting on conditions of use, authentication and evaluation, preservation and interoperability.
Policy on the use of Artificial Intelligence
Recent major advances in big language models—sophisticated generative artificial intelligence (AI) algorithms trained on massive amounts of language data—have given rise to widely available writing tools, such as Open AI’s popular chatbot ChatGPT, that can analyze text and produce new content in response to user input. This technology has important and immediate implications for academics writing papers and for the journals that publish them.
Large language models have a powerful ability to search and repackage information from their training dataset into a wide variety of formats and styles that users can specify. They can be used to generate ideas and outlines for academic manuscripts, or even the full text of articles. Because contemporary AI tools can be remarkably well trained to mimic human speech and writing styles, their output can closely resemble that of a human author and can convey the impression of accuracy and authority, as well as an emotional connection.
Requirements for reporting the use of AI-assisted technologies for manuscripts submitted to Acta Medica (based on recommendations from the International Committee of Medical Journal Editors)
Acta Medica requires authors to declare any use of AI-assisted technologies in any aspect of the creation of the submitted work.
Artificial intelligence and AI-assisted technologies should not be listed as an author or co-author of a manuscript.
Artificial intelligence and AI-assisted technologies should not be cited as a reference or other primary source or as the author of a reference.
Human authors are responsible for any submitted material that includes the use of AI-assisted technologies, including its correctness, completeness, and accuracy.
Authors must be able to assert that there is no plagiarism in the article, including text and images produced by AI-assisted technologies, and must ensure proper attribution of all material, including full citations where appropriate.
Peer reviewers should not upload manuscripts to software or other artificial intelligence technologies where confidentiality cannot be guaranteed.
Even if AI-assisted technologies are used in a way that can ensure the confidentiality of the manuscript, reviewers who choose to use such technologies to facilitate their review must declare their use and nature and are responsible for ensuring that any AI-generated content incorporated into reviews is accurate, complete, and unbiased.
Policy on Diversity, Equity, Inclusion and Accessibility (IDEIA)
Acta Medica publishes scientific articles selected through a peer review process without any discrimination. It promotes Diversity, Equity and Inclusion in research and the communication of scientific results.
